|
 | Up a level |
Wei, Yuxuan, Zhang, Yichen, Xu, Ziyue, Wang, Guoan, Zhou, Yue, Li, Huangqianyu, Shi, Luwen, Naci, Huseyin 
ORCID: 0000-0002-7192-5751, Wagner, Anita K. and Guan, Xiaodong
(2024)
Cancer drug indication approvals in China and the United States: a comparison of approval times and clinical benefit, 2001–2020.
The Lancet Regional Health - Western Pacific, 45.
ISSN 2666-6065
Zhou, Yue, Naci, Huseyin ORCID: 0000-0002-7192-5751, Chen, Dingyi, Bai, Lin, Shi, Luwen, Guan, Xiaodong and Wagner, Anita Katharina
(2023)
Overall survival benefits of cancer drugs in the WHO Model List of Essential Medicines, 2015–2021.
BMJ Global Health, 8 (9).
ISSN 2059-7908
Zhang, Yichen, Naci, Huseyin ORCID: 0000-0002-7192-5751, Wagner, Anita K., Xu, Ziyue, Yang, Yu, Zhu, Jun, Ji, Jiafu, Shi, Luwen and Guan, Xiaodong
(2022)
Overall survival benefits of cancer drugs approved in China from 2005 to 2020.
JAMA network open, 5 (8).
ISSN 2574-3805
